Stefano Ugel

16PUBLICATIONS
87CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 22, 2026
c-FLIP as a master regulator of immune homeostasis and disease mechanisms.

|Oct 28, 2025
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells.

Federica Danzi, Giovanna Butera, Damien Sutton

|Dec 05, 2024
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance.

A Esposito, A Agostini, G Quero

|Jun 24, 2024
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications.

Marco Sposito, Serena Eccher, Luca Pasqualin

|Sep 18, 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.

Annalisa Adamo, Cristina Frusteri, Sara Pilotto

|May 11, 2023
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response.

Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella

Pageof 3

Frequent Collaborators

11 joint publications

Vincenzo Bronte

4 joint publications

Manuela Iezzi

2 joint publications

Francesco De Sanctis

2 joint publications

Vincenzo Corbo